The Filing Desk

Pennant Group

PNTG · Nasdaq · Health Care · Financials, fiscal 2017 to 2025

PNTG · Last close · November 13, 2026
$36.07
Value Pennant Group yourself

Pennant Group's revenue rose 36.3% to $948 million in fiscal 2025. Its operating margin was 5.5%, about the same as 5.5% a year earlier. Free cash flow was $36 million, up 19.6%. The diluted share count rose 10.4%.

THE PENNANT GROUP, INC. Latest fiscal year ended December 31, 2025 10-K filed February 26, 2026 · 0001766400-26-000014 Updated
Revenue
$948M
36.3%
Operating margin
5.5%
0.0 pts
Net income
$30M
31.1%
Free cash flow
$36M
19.6%
Return on capital
9.3%
2.7 pts
Market cap
$1.3B
Nov 13 close
P/E
36.1x
On $1.00 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Pennant Group does

Pennant Group provides home health, hospice and senior living services in the United States. It runs home health and hospice through 172 agencies and senior living through 63 communities that offer assisted living, independent living and memory care. It operates in sixteen states and provides operational support in Connecticut.

It reports two segments: home health and hospice, which also includes home care and geriatric primary and palliative care, and senior living. It gets revenue from Medicare and Medicaid, private-pay patients and residents, and managed care payors. Medicare supplied 48.4% of its revenue in 2025. The 10-K says healthcare is local and that Pennant gives its local leaders the authority to run each operation, with support from a service center.

Pennant became a separate company in 2019 when The Ensign Group spun it off. Payroll is its main expense.

Its biggest risks, as it describes them

  • Medicare reimbursement changes could cut its revenue.
  • Cuts to Medicaid payment rates or rule changes could hurt it.
  • Competition for nurses and caregivers could raise its labor costs.
  • It may be unable to acquire or open operations on good terms.
  • Government audits and investigations, and rules for healthcare providers, could bring penalties.
From Pennant Group's annual report on Form 10-K, filed February 26, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2017 to 2025, earnings per share grew 11.2% a year and net income 14.7% a year, as new shares raised the share count by 27% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments5262417
Debt incl. finance leases5163641176
Net debt (negative means net cash)466158−23158
Net debt to EBITDA4.9x3.5x1.9x−0.5x2.6x
Debt to equity0.5x0.5x0.4x0.0x0.5x
Interest coverage2.4x3.3x4.2x5.5x7.8x
Current ratio1.1x1.1x1.1x1.2x1.1x
Quick ratio1.1x1.1x1.1x1.2x1.1x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Pennant Group's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Pennant Group shares on the open market, and 3 insiders sold $690,087, all of it under trading plans set up in advance.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Aug 6, 2026Brent GuerisoliChief Executive OfficerSold plan4,285$38.52$165,058Form 4
Aug 6, 2026Jason Paul SteikChief Clinical OfficerSold plan1,394$38.52$53,697Form 4
Aug 6, 2026Kirk Sterling CheneyEVP, GC and Corp SecySold plan1,393$38.52$53,658Form 4
Jul 10, 2026Brent GuerisoliChief Executive OfficerSold plan3,159$41.57$131,320Form 4
Jul 7, 2026Brent GuerisoliChief Executive OfficerSold plan3,165$40.51$128,214Form 4
May 22, 2026Brent GuerisoliChief Executive OfficerSold plan4,508$35.08$158,140Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score6 of 87 of 85 of 8
Rule of 4019.7%31.9%40.1%
Altman Z''1.011.751.45
Accruals ratio−3.8%−2.8%−2.3%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassPassPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsFailPassFail
Current ratio rosePassPassFail
Share count didn't riseFailFailFail
Gross margin rose———
Revenue rose relative to assetsPassPassPass
F-score6 of 87 of 85 of 8
Companies that report no gross profit are scored on the other eight.

Compare

Put Pennant Group side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Pennant GroupFY2536.3%5.5%3.8%9.3%2.6x5
CorVelFY267.0%—11.5%———Compare
Myriad GeneticsFY25−1.6%−47.0%−1.7%−62.6%—5Compare
Sotera HealthFY255.7%—12.8%6.7%—7Compare
NeoGenomics LaboratoriesFY2510.1%−15.9%−3.0%−8.8%—5Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

9 years of figures

Fiscal yearFY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue251286338391440473545695948
Revenue growth—14.0%18.3%15.5%12.5%7.6%15.1%27.6%36.3%
Gross profit—————————
Research and development—————————
Operating income1521619513253852
Net income101621637132330
Diluted EPS (US$)0.360.580.110.520.090.220.440.700.84
Diluted shares (millions)282830303130303235
Cash flow
Cash from operations17231050−189333948
Capital expenditure34776148912
Free cash flow1420343−25−5253036
Dividends paid0012000000
Share buybacks000000000
Acquisitions125193314102148204
Stock-based compensation2238103589
Balance sheet at fiscal year end
Cash and short-term investments00005262417
Debt incl. finance leases—01885163641176
Total assets—98448507530512540680968
Total liabilities—33377406416386394368594
Shareholders' equity606571101114126146312374
Margins and ratios
Gross margin—————————
Operating margin6.1%7.2%1.7%4.8%1.1%2.7%4.6%5.5%5.5%
Net margin3.9%5.5%0.8%4.0%0.6%1.4%2.5%3.2%3.1%
Free cash flow margin5.6%6.9%0.8%11.0%−5.6%−1.1%4.6%4.4%3.8%
Rule of 40 (growth + FCF margin)—20.9%19.2%26.5%6.9%6.5%19.7%31.9%40.1%
Return on capital——4.4%16.6%2.7%6.0%9.2%12.0%9.3%
Return on equity——3.7%18.3%2.5%5.5%9.9%9.9%8.6%
Return on assets——0.9%3.3%0.5%1.3%2.5%3.7%3.6%
Net debt to EBITDA—−0.0x1.9x0.3x4.9x3.5x1.9x−0.5x2.6x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Pennant Group's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Pennant Group.